Redhill Biopharma
RDHL
#11160
Rank
C$3.58 M
Marketcap
C$0.40
Share price
-13.08%
Change (1 day)
-72.50%
Change (1 year)

Earnings for Redhill Biopharma (RDHL)

Earnings in 2022: -C$0.11 Billion

According to Redhill Biopharma's latest financial reports the company's current earnings are C$35.74 Million. In 2022 the company made an earning of -C$0.11 Billion, an increase over its 2021 earnings that were of -C$0.15 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Redhill Biopharma from 2012 to 2022

Annual earnings

Year Earnings Change
2022-C$0.11 Billion-26.68%
2021-C$0.15 Billion28.32%
2020-C$0.11 Billion80.06%
2019-C$60.67 Million8.97%
2018-C$55.67 Million-14.76%
2017-C$65.32 Million55.07%
2016-C$42.12 Million39.26%
2015-C$30.25 Million96.9%
2014-C$15.36 Million0.78%
2013-C$15.25 Million16.93%
2012-C$13.04 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sanofi
SNY
C$11.16 B 67,200.64%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
C$9.64 B 57,997.13%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$10.25 B 61,725.70%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
C$1.75 B 10,477.26%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Taro Pharmaceutical
TARO
C$62.7 M 277.87%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel